Best Transarterial Radioembolization- TARE Hospitals in Turkey

Acibadem International Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1989, the JCI hospital is situated in Istanbul, Turkey and has 112 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Memorial Ankara Hospital offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 2014, the JCI hospital is located in Ankara, Turkey and has 230 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Medipol Bahçelievler Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2022, the JCI hospital is situated in Istanbul, Turkey and has 441 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Choosing Florence Nightingale Hospital for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1989, the JCI hospital in Istanbul, Turkey has 804 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Choosing Antalya Anadolu Hastanesi for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 2006, the hospital in Antalya, Turkey has 114 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

At Istinye University Medical Park Gaziosmanpasa Hospital, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 2015, this ISO, JCI hospital in Istanbul, Turkey has 197 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

At Liv Hospital Ulus, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 2013, this JCI hospital in Istanbul, Turkey has 154 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Choosing Medicana International Ankara Hospital for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 2008, the JCI hospital in Ankara, Turkey has 215 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Medicana International Istanbul offers advanced Transarterial Radioembolization (TARE) using modern interventional radiology techniques and internationally accepted treatment protocols. Established in 1992, the JCI hospital is located in Istanbul, Turkey and has 186 beds, providing comprehensive care for local and international patients.

Transarterial Radioembolization (TARE) is a minimally invasive treatment primarily used for certain liver cancers and tumors that have spread to the liver. During the procedure, tiny radioactive microspheres are delivered through the hepatic artery to the tumor, where they release radiation locally while limiting exposure to surrounding healthy liver tissue. Before treatment, doctors generally perform imaging and other assessments to determine whether TARE is appropriate. Follow-up imaging helps evaluate the treatment response.

Memorial Antalya Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2010, the JCI hospital is situated in Antalya, Turkey and has 114 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

At VM Medical Park Ankara, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 2014, this JCI hospital in Ankara, Turkey has 327 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Ekol is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2000, the ISO hospital is situated in Izmir, Turkey and it has adequate bed capacity.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

At Bayindir Healthcare Group, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1992, this JCI hospital in Ankara, Turkey has 153 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Acibadem University Hospital Atakent is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2014, the JCI hospital is situated in Istanbul, Turkey and has 278 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Istinye University Bahcesehir - LIV Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 2016, the ISO, JCI hospital is situated in Istanbul, Turkey and has 394 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.